Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors
Open Access
- 27 November 2023
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (1) , 142-153
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81972718)
- Natural Science Foundation of Zhejiang Province
This publication has 26 references indexed in Scilit:
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategiesScience, 2018
- Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysisThe Lancet Oncology, 2018
- Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung CancerJAMA Oncology, 2018
- Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303)International Journal of Clinical Oncology, 2017
- Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trialThe Lancet Oncology, 2017
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer ProgressionCell, 2015
- Immunological mechanisms of the antitumor effects of supplemental oxygenationScience Translational Medicine, 2015
- Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)Biochemical Society Transactions, 2013
- Surgery in Esophageal and Gastric Cancer Patients: What is the Role for Nutrition Support in your Daily Practice?Annals of Surgical Oncology, 2012
- The role of albumin in critical illnessBritish Journal of Anaesthesia, 2000